Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2021C559 Product name: bimekizumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2021C/559
Type:
Certificate
SPC type:
Medical
Basic patent number:
127004331
Status:
Open & Published
Publication number:
2021C559
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/21/1575
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
23/08/2021
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
20/12/2021
First marketing authorization date:
23/08/2021
Grant date:
Activation date:
BE Publication date:
21/12/2021
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
23/08/2036
SPC/SPC Extension Expiration (if granted and all annual fees paid):
23/08/2036
Rejection date:
Withdrawal date:

Applicant

Name:
UCB BIOPHARMA SRL
Legal Form:
BV: besloten vennootschap
From:
21/12/2021
Address:
Allée de la Recherche 60, 1070, Brussel, Belgium (BE)
To:

Agent

1

Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:

2

Name:
GEVERS PATENTS
Legal Form:
From:
21/12/2021
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024

Publication

Bulletin

Bulletin heading:
SPC
Journal edition number:
2021/24
Publication date:
02/02/2022
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

Annual fee

Annual fee(s) Due Date:
02/02/2032
Annual fee number:
21
Annual fee amount:
650 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
20/12/2021 Marketing Authorization 1st Marketing Authorization (EU) 3 PDF /9/9/4/8/8/0722188499/docs/2021c559_0_marketingauthorization_20211221_084608432.pdf
20/12/2021 MA Official Publication Official Publication of 1st Marketing Authorization 8 PDF /9/9/4/8/8/0722188499/docs/2021c559_1_maofficialpublication_20211221_084609037.pdf
21/12/2021 Publication I1 1 PDF /9/9/4/8/8/0722188499/docs/2021c559_2_i1document_20211221_101858566.pdf
21/12/2021 Outgoing Correspondence 2 PDF /9/9/4/8/8/0722188499/docs/2021c559_3_outgoingcorrespondence_20220117_104735322.pdf
20/12/2021 Abstract Product Characteristics Abstract of the characteristics of the product 57 PDF /9/9/4/8/8/0722188499/docs/2021c559_4_abstractproductcharacteristics_20211221_084609569.pdf
20/12/2021 General Document Other 3 PDF /9/9/4/8/8/0722188499/docs/2021c559_5_generaldocument_20211221_084607099.pdf
20/12/2021 Application Form 4 PDF /9/9/4/8/8/0722188499/docs/2021c559_6_applicationform_20211221_084610363.pdf
08/02/2024 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /9/9/4/8/8/0722188499/docs/2021c559_7_rfc_20240425_085642791.pdf